A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
Year: 2022
Type: article
Abstract: SGLT2 inhibitors may have a potential to stop the decline of renal function independent of the stage of albuminuria in diabetic kidney disease, and can be a new light in the post-RAS inhibitor era.
DOI: 10.1111/jdi.13747
Authors: Shinji Kume, Hiroshi Maegawa
Institution: Shiga University of Medical Science
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,850
OpenAlex ID: W4205735416